Seritan Andreea L, Bourgeois James A, Schneider Andrea, Mu Yi, Hagerman Randi J, Nguyen Danh V
Department of Psychiatry and Behavioral Sciences, University of California Davis Medical Center, Sacramento, California ; Medical Investigation of Neurodevelopmental Disorders (M.I.N.D.) Institute, University of California Davis Medical Center, Sacramento, California.
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada.
Curr Psychiatry Rev. 2013 Feb;9(1):65-71. doi: 10.2174/157340013805289662.
premutation carriers of both genders have a high lifetime prevalence of anxiety and depressive disorders, however little is known regarding the onset ages of these conditions. This study compared onset ages of mood and anxiety disorders in premutation carriers with typical onset ages of the same disorders in the general population.
Eighty-one premutation carriers (42% men; average age 62, SD 10) with and without FXTAS completed the Structured Clinical Interview for DSM-IV-TR. Onset ages of mood and anxiety disorders were compared to the corresponding typical population onset ages using the signed rank test.
Overall median onset ages of MDD (46 years old, p < 0.0001), panic disorder (40 years old, p = 0.0067), and specific phobia (11.5 years old, p = 0.0003) were significantly higher in premutation carriers compared to the general population. Median MDD onset ages in male carriers (52 years old) and those with FXTAS (49.5 years old) were significantly higher relative to the general population (median 32, both p < 0.0001). Tremor and ataxia emerged significantly later than MDD and the anxiety disorders studied.
Depressive and anxiety disorders in premutation carriers have a later onset compared to the general population, but precede the onset of motor symptoms. This may be due to progressive mRNA toxicity in the limbic system, white matter changes leading to neuronal dysconnectivity, and interaction with environmental factors. Psychosocial factors may be protective. Further research is needed to understand the full spectrum of psychiatric phenotypes in premutation carriers.
男女前突变携带者一生中患焦虑症和抑郁症的比例都很高,但对于这些疾病的发病年龄却知之甚少。本研究比较了前突变携带者中情绪和焦虑障碍的发病年龄与普通人群中相同障碍的典型发病年龄。
81名有或无脆性X震颤性共济失调综合征(FXTAS)的前突变携带者(42%为男性;平均年龄62岁,标准差10)完成了《精神疾病诊断与统计手册》第四版修订版(DSM-IV-TR)的结构化临床访谈。使用符号秩检验将情绪和焦虑障碍的发病年龄与相应的典型人群发病年龄进行比较。
与普通人群相比,前突变携带者中重度抑郁症(MDD)的总体中位发病年龄(46岁,p<0.0001)、惊恐障碍(40岁,p = 0.0067)和特定恐惧症(11.5岁,p = 0.0003)显著更高。男性携带者(52岁)和患有FXTAS的携带者(49.5岁)的MDD中位发病年龄相对于普通人群(中位年龄32岁,p均<0.0001)显著更高。震颤和共济失调出现的时间明显晚于MDD和所研究的焦虑症。
与普通人群相比,前突变携带者中的抑郁症和焦虑症发病较晚,但早于运动症状出现。这可能是由于边缘系统中逐渐增加的mRNA毒性、导致神经元连接障碍的白质变化以及与环境因素的相互作用。社会心理因素可能具有保护作用。需要进一步研究以了解前突变携带者中精神疾病表型的全貌。